GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Proteomics International Laboratories Ltd (ASX:PIQ) » Definitions » FCF Yield %

Proteomics International Laboratories (ASX:PIQ) FCF Yield % : -8.67 (As of Apr. 02, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Proteomics International Laboratories FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Proteomics International Laboratories's Trailing 12-Month Free Cash Flow is A$-5.51 Mil, and Market Cap is A$63.54 Mil. Therefore, Proteomics International Laboratories's FCF Yield % for today is -8.67%.

The historical rank and industry rank for Proteomics International Laboratories's FCF Yield % or its related term are showing as below:

ASX:PIQ' s FCF Yield % Range Over the Past 10 Years
Min: -20.07   Med: -6.57   Max: -1.67
Current: -8.67


During the past 10 years, the highest FCF Yield % of Proteomics International Laboratories was -1.67%. The lowest was -20.07%. And the median was -6.57%.

ASX:PIQ's FCF Yield % is ranked better than
60.28% of 1498 companies
in the Biotechnology industry
Industry Median: -15.56 vs ASX:PIQ: -8.67

Proteomics International Laboratories's FCF Margin % for the quarter that ended in Dec. 2024 was -195.39%.


Proteomics International Laboratories FCF Yield % Historical Data

The historical data trend for Proteomics International Laboratories's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteomics International Laboratories FCF Yield % Chart

Proteomics International Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.08 -2.48 -3.73 -6.64 -5.21

Proteomics International Laboratories Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.29 -7.70 -3.13 -7.43 -2.35

Competitive Comparison of Proteomics International Laboratories's FCF Yield %

For the Biotechnology subindustry, Proteomics International Laboratories's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteomics International Laboratories's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Proteomics International Laboratories's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Proteomics International Laboratories's FCF Yield % falls into.


;
;

Proteomics International Laboratories FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Proteomics International Laboratories's FCF Yield % for the fiscal year that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-5.996 / 115.18584
=-5.21%

Proteomics International Laboratories's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.229 * 2 / 104.8024
=-2.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteomics International Laboratories FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Proteomics International Laboratories FCF Yield % Related Terms

Thank you for viewing the detailed overview of Proteomics International Laboratories's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteomics International Laboratories Business Description

Traded in Other Exchanges
Address
6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. The company specializes in the area of proteomics which is the industrial-scale study of the structure and function of proteins. Its operations are divided into PromarkerD which targets the diabetes epidemic and is a predictive diagnostic test for diabetic kidney disease, a progressive disorder found in one in three adults with diabetes; its proprietary biomarker discovery platform called Promarker, which searches for protein fingerprints in a sample; and Analytical Services that are specialist contract research focusing on biosimilars quality control and pharmacokinetic testing for clinical trials.

Proteomics International Laboratories Headlines

No Headlines